AZ’ Farxiga fast-tracked for heart failure following MI
The move is based on the first indication-seeking registry-based randomised controlled trial
Read More
Tag: DAPA-MI trial
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
